Dermal Fillers: The Complete Guide for Clinics & Distributors
Dermal fillers are medical devices injected under the skin to restore volume, soften folds or rebuild facial support. Four facts decide almost everything a clinic, distributor or OEM buyer needs to know about them: they are regulated as devices rather than drugs, most are temporary because the body breaks the material down, the material inside the syringe sets how long the result lasts, and the area being treated sets which material is appropriate in the first place.
This is the hub page for the whole AuroThread dermal filler cluster. Every section below states the essential point in a short summary and links to the single article that covers that subject in full, so the page reads end to end without repeating the specialist guides paragraph by paragraph.
It is written for clinics, distributors and OEM buyers rather than patients. Nothing here is a treatment recommendation, and injection decisions remain the responsibility of a licensed treating practitioner.
Key takeaways
• The FDA regulates dermal fillers as medical devices, approved for specific uses in people aged 22 and older.
• Four material families dominate: hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid and PMMA. Only PMMA is non-absorbable.
• Published duration figures describe material classes (HA ~6–12 months, CaHA ~18 months, PLLA up to 2 years), not individual outcomes.
• The most serious risk is unintended injection into a blood vessel, which can cause tissue death, stroke or blindness.
• For B2B buyers, six documented parameters decide whether a product is actually purchasable: material and origin, concentration, particle metrics, needle compatibility, sterilisation and certification.
Choose your path
Five routes through the cluster. Each route opens one specialist page.
Compare Materials
Hyaluronic acid, CaHA, PLLA and PMMA side by side — what each one is, how long it lasts and what it is specified for.
Types of dermal fillers →Understand Ingredients
What is actually inside the syringe: the base material, the cross-linker, the carrier and the additives that change handling.
What are dermal fillers made of? →Understand Mechanisms
Why two products with the same stated duration can look completely different in the first month after treatment.
How do dermal fillers work? →Plan a Clinic Formulary
How facial anatomy, tissue plane and vascular risk translate into which grades a clinic actually needs to stock.
Facial fillers guide →Verify a Supplier
The document set, sample process and product-specific commercial terms to request before a first order.
Dermal filler supplier checklist →1. What Dermal Fillers Are, in Brief
The FDA defines dermal fillers as gel-like substances injected under the skin to create a smoother or fuller appearance, or both, and regulates them as medical devices rather than drugs. That single distinction drives the paperwork: a device is documented by a technical file, a declaration of conformity and a lot certificate, not by a pharmaceutical dossier. The agency also notes that the effect of most fillers is temporary, because the materials are eventually broken down and absorbed.
Approved uses are specific rather than general: moderate-to-severe facial wrinkles and folds, fullness in the lips, cheeks, chin, under-eye hollows, jawline and back of the hand, facial fat loss in people with HIV, and acne scars on the cheek. An approved material is therefore not automatically an approved use in every zone. A filler is also not a skinbooster: the filler is structured to restore volume or fill a depression at a defined depth, while a skinbooster is a low-viscosity formulation for superficial microinjection aimed at skin quality.
2. The Four Material Families
Almost every product you will be quoted belongs to one of four families, and the family explains most of its commercial behaviour: what it can be sold for, how it is stored, and how the result develops over time. Three are absorbed and one is not.
| Family | What it is | FDA-described duration | Absorbed? |
| Hyaluronic acid | A sugar naturally found in the body; binds water and swells in gel form, often cross-linked to slow breakdown. | ~6–12 months | Yes |
| Calcium hydroxylapatite | A mineral and major component of bone, placed as particles in a gel carrier; visible on x-ray. | ~18 months | Yes |
| Poly-L-lactic acid | A biodegradable synthetic polymer; biostimulatory, given as a series of sessions. | Up to 2 years | Yes |
| PMMA beads | Tiny round smooth plastic beads suspended in a solution containing bovine collagen. The only FDA-approved non-absorbed filler. | Not absorbed | No |
Two negative facts belong alongside that table. The FDA has not approved injectable silicone, or any injectable filler, for body contouring or enhancement, and warns against injecting filler into the breasts, buttocks or the spaces between muscles. It has also not approved needle-free devices for injecting dermal fillers, because the high pressure gives insufficient control over where material lands.
Full comparison: Types of dermal fillers — the family-by-family breakdown, including which grades suit which depth.
3. What Is Actually Inside the Syringe
A filler is not a single substance. Four components decide how it behaves and what a buyer should ask about. The base material is the family above; for hyaluronic acid the relevant detail is origin, because non-animal fermentation removes a category of consent and allergy questions that animal-derived material keeps. The cross-linker is what turns free HA chains into a network that resists breakdown — BDDE is the common one, and the meaningful figure is the residual limit declared on the technical data sheet, not the word “cross-linked”. The carrier holds the active particles: CaHA microspheres sit in a gel carrier, PLLA is supplied as a lyophilised powder for reconstitution. Additives such as lidocaine change handling and comfort, and must be declared.
For procurement the question is not “what is it made of” in the abstract but whether all four are stated on paper, at the level of the specific SKU being quoted. A range-level statement and a grade-level statement are not interchangeable on a purchase order.
Full article: What are dermal fillers made of?
4. How They Work
The three absorbable families do not work the same way, and treating “filler” as one mechanism produces wrong expectations at the clinic desk. Hyaluronic acid works physically: the gel occupies space and binds water, so the effect is visible immediately and fades as the material is absorbed. Calcium hydroxylapatite works by suspension: mineral particles carried in a gel provide structural support, the carrier is absorbed and the particles are metabolised over a longer period. Poly-L-lactic acid works biologically: the American Society for Dermatologic Surgery describes it as biostimulatory — stimulating the skin to produce new collagen — with the polymer eventually broken down into water and carbon dioxide. Because the result comes from the patient's own tissue response, it develops gradually over a few months and is delivered as a series of sessions.
This is the origin of the most common commercial misunderstanding in the category: two products with the same stated duration can behave completely differently in the first month. One is visible on the day of treatment, the other is not visible until weeks later, and a clinic quoting a single “results timeline” across its range is not describing its products accurately.
Full article: How do dermal fillers work?
5. Choosing by Facial Area: Building a Formulary
In practice a filler is selected by area before it is selected by material, because what changes between zones is the tissue it has to sit in: skin thickness, plane mobility, vascular anatomy and mechanical load. A clinic formulary is therefore a map of zones to grades, not a list of brands. The table below shows the mapping AuroThread publishes; the plane and particle band matter more than the product name.
| Zone | Plane targeted | Particle band | AuroThread grade |
| Tear trough | Upper dermis, thin skin | 0.10–0.15 mm | Fine |
| Lips and peri-oral | Upper to mid dermis | 0.10–0.28 mm | Fine / Derm |
| Nasolabial and marionette lines | Mid to deep dermis | 0.15–0.28 mm | Derm |
| Mid-cheek and malar | Deep dermis to subdermal | 0.28–0.50 mm | Deep / CaHA |
| Temple, chin, jawline | Deep dermis / surface subcutis | 0.28–0.50 mm | Deep |
| Back of hand, body volume | Deepest plane | 0.5–1.25 mm | Subskin |
Two constraints sit outside the hyaluronic acid column and are frequently missed. The ASDS states that poly-L-lactic acid is not appropriate for lip augmentation, close to the eyes, or fine lines around the mouth. And the FDA's approved-use list does not cover every conceivable zone, so a product can be correctly specified as a material and still be wrong for an area. The zone with the highest vascular risk is also the one where cannula and needle gauge selection differs most — which is why compatibility belongs on the data sheet rather than in a brochure.
Full article: Facial fillers: the clinic formulary guide
Specifying a filler range for a clinic or distributorship?
Ask for the specification sheet, sample options and product-specific MOQ for the grades you are evaluating. Commercial terms are quoted per SKU rather than published as one number, because concentration, volume and packaging configuration differ by grade.
Browse the dermal filler range Request specification sheet Auro Secret range
6. Buying Dermal Fillers: What Decides the Purchase
Because a filler is a device, six documented parameters decide whether a product is actually purchasable: material and origin, which sets the regulatory pathway and labelling; concentration in mg/mL, without which “1 mL syringe” says nothing about how much material is inside; particle size and count per mL, which determines the tissue plane and therefore what the product can be sold for; needle and cannula compatibility, which determines the consumables a clinic must stock; sterilisation, packaging and shelf life, which affect storage, shipping cost and how much stock a distributor can hold; and certification and quality system, which decides whether the product can be registered in the destination market at all.
The documentation set to request before a first order has four parts. Regulatory: a CE certificate identifying the classification and notified body, and an ISO 13485 certificate with its scope and validity dates. Product: a specification sheet stating material, origin, concentration, particle distribution, cross-linker and residual limits, volume per syringe, and whether lidocaine is present. Batch: a certificate of analysis for the specific lot, since a generic certificate not linked to a lot proves very little. Commercial: packaging configuration, units per carton, MOQ per SKU, lead time and Incoterms.
A supplier that answers four of these and deflects the rest is telling you something useful about which parts of its operation are documented.
Full checklist: Dermal filler supplier checklist: documents, MOQ and samples
7. How Long They Last
Duration is the most-quoted and least-defined number in the category. Three different figures can legitimately describe the same material, and conflating them is how a specification drifts away from reality. A regulatory figure characterises a material class across the products a regulator reviewed; a manufacturer figure describes a named graded range from one producer; an observed outcome belongs to one patient, one area and one injection plane. AuroThread's published HA range states 6–18 months across its Fine, Derm and Deep grades, which extends beyond the FDA's class-level characterisation — that is not a contradiction, but it is a claim a buyer should be able to interrogate against the technical file.
| Type of figure | What it describes | HA example |
| Regulatory characterisation | The material class, across the products a regulator reviewed | ~6–12 months (FDA) |
| Manufacturer specification | A named graded range from one producer | 6–18 months across Fine, Derm and Deep (AuroThread) |
| Observed outcome | One patient, one area, one injection plane | Varies with plane, volume, vascularity and metabolism |
The FDA adds a point that matters for consent as much as for procurement: if a filler needs to be removed or reduced because of side effects, additional procedures or surgery may be required, those carry their own risks, and it may be difficult or impossible to remove some filler materials. For hyaluronic acid there is an enzymatic reversal option; for the biostimulatory and permanent families there is not.
8. Safety and Side Effects
The following is summarised from the FDA's consumer guidance.
Who may not be suitable. The FDA notes dermal fillers may not be appropriate for people with certain conditions, such as bleeding disorders or some allergies, and that people should be tested for allergies before receiving fillers made with certain materials, especially materials derived from animals such as collagen.
Common risks. Bruising, redness, swelling, pain, tenderness, itching and rash, most occurring shortly after injection and many resolving within days to weeks. Less common risks include inflammation near the injection site following viral or bacterial illness, vaccination or dental procedures; raised bumps or nodules and granulomas that may need injection, oral antibiotics or surgical removal; infection; open or draining wounds; a sore at the injection site; allergic reaction; and necrosis.
The most serious risk is unintended injection into a blood vessel. Filler entering a vessel can cause skin necrosis, stroke or blindness; the FDA describes the chance as low but the resulting complications as serious and potentially permanent.
Three further warnings matter to anyone specifying or importing product. The FDA warns against buying or using lip or facial fillers sold directly to the public, because they are not approved and may be contaminated with chemicals and infectious organisms; It also warns against needle-free injection devices and against any filler or liquid silicone injected for body contouring. For buyers that translates into a due-diligence rule: a supplier who will sell to a non-clinical buyer without verification, or who offers silicone or needle-free delivery, has disqualified itself regardless of price.
9. Fillers Versus Botox
The FDA is explicit that botulinum toxin products — Botox, Dysport, Xeomin and Jeuveau among them — are not dermal fillers. They are injectable drugs that work by keeping muscles from tightening, so wrinkles show less; fillers are devices that add volume to tissue. One regulatory caveat is worth stating precisely: the FDA notes that the safe use of dermal fillers in combination with Botox and other treatments has not been evaluated in clinical studies, so combined treatment is widespread and reported in the literature but is not a regulator-evaluated protocol. AuroThread manufactures fillers, skinboosters and threads, and does not manufacture or supply botulinum toxin.
Full article: Dermal filler vs Botox
10. The AuroThread Range
9. The AuroThread Range
AuroThread manufactures across three of the four absorbable families, which means a clinic can consolidate documentation from one quality system instead of reconciling certificates from three vendors. The specifications below are as published on AuroThread's product data.
| Family | Line | Format | Stated duration |
|---|---|---|---|
| Hyaluronic acid | Auro Secret / Auro Secret Plus (Fine, Derm, Deep, Subskin) | 1 mL, 2 mL, 3 mL and 10 mL syringes, individually packaged | 6–18 months |
| Calcium hydroxylapatite | UniCaHA Dual | 1.1 mL syringe; 56% CaHA microspheres, 25–45 µm | Class characterised at ~18 months |
| Poly-L-lactic acid | Angelfill | 150 mg lyophilised vial; 2-year expiry | 2–3 years per session |
Across the HA range the published specification states non-animal origin, BDDE cross-linking with residual content below the regulatory threshold, 20–24 mg/mL varying by viscosity grade at range level and 20 mg/mL on the individual Fine, Derm and Deep pages; sterilisation by moist heat terminal process (Auro Secret Plus specified at 121°C high-pressure steam); a two-year shelf life; storage at 2–25°C; compatibility with 27G–30G needles and 22G–30G blunt cannulas; and certification described as CE mark, ISO 13485 and GMP manufacturing.
Where a range-level figure and a grade-level figure differ, the grade-level figure is the one that belongs on a purchase order, and a buyer is entitled to ask which applies to the SKU being quoted.
Fine
0.10–0.15 mm · 200,000 particles/mL · 27G · upper dermis
The finest graded HA in the range, for thin overlying skin and shallow planes.
View Product
Deep
0.28–0.50 mm · 10,000 particles/mL · 26G · deep dermis
A larger-particle HA for cheek, temple and jawline support where the plane sits deeper.
View Product
UniCaHA Dual
56% CaHA · 25–45 µm · 1.1 mL · deep dermal to subdermal
Mineral microspheres in a gel carrier, characterised at approximately 18 months.
View Product
Angelfill
PLLA · 150 mg vial · biostimulatory · 2–3 years
A lyophilised polymer given as a series, with results building over months.
View Product11. Where to Read Next
Each specialist guide below is the single home for its subject, which is why this page only summarises them.
Materials and ingredients. Types of dermal fillers · What are dermal fillers made of?
Mechanism and application. How do dermal fillers work? · Facial fillers guide · Dermal filler vs Botox
Specification and procurement. How to read a filler specification sheet · Dermal filler supplier checklist · dermal filler range · CaHA collection · PLLA collection
12. Frequently asked questions
Select a question to open the answer.
What are dermal fillers?
The FDA defines them as gel-like substances injected under the skin to create a smoother or fuller appearance. It regulates them as medical devices, and most are temporary because the body breaks the material down.
What are the four types of dermal filler?
Hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid and PMMA beads. The first three are absorbed over time; PMMA is the only FDA-approved non-absorbed filler.
How long do dermal fillers last?
By material class: hyaluronic acid approximately 6–12 months, calcium hydroxylapatite approximately 18 months, poly-L-lactic acid up to 2 years. AuroThread's specification for its Fine, Derm and Deep HA grades states 6–18 months across the graded range.
Are dermal fillers safe?
They carry a documented risk profile. The FDA lists common effects such as bruising, redness, swelling and tenderness, less common effects including nodules, infection and necrosis, and identifies unintended injection into a blood vessel as the most serious risk, capable of causing tissue death, stroke or blindness.
Are dermal fillers the same as Botox?
No. The FDA states botulinum toxin products are not dermal fillers: they are injectable drugs that keep muscles from tightening. Fillers restore volume; toxin reduces movement. They are also regulated differently — device versus prescription drug.
Is it safe to combine fillers with Botox?
The FDA notes that the safe use of dermal fillers in combination with Botox and other treatments has not been evaluated in clinical studies. Combined treatment is widely reported in practice, but it is not a regulator-evaluated protocol.
Is silicone a dermal filler?
No. The FDA has not approved injectable silicone or any injectable filler for body contouring or enhancement, and warns against injecting filler into the breasts, buttocks or spaces between muscles.
Can dermal fillers be removed?
Not always easily. The FDA notes that additional procedures or surgery may be required to reduce or remove a filler, that those procedures carry their own risks, and that it may be difficult or impossible to remove some filler materials.
What is the difference between a filler and a skinbooster?
A filler restores volume or fills a depression at a defined depth. A skinbooster is a low-viscosity, non-volumising HA formulation for superficial microinjection aimed at skin quality. Both may be hyaluronic acid but they are specified and priced differently.
What should a clinic check before buying fillers wholesale?
Six parameters and four documents. The parameters are material and origin, concentration, particle size and count, needle compatibility, sterilisation and shelf life, and certification. The documents are a CE certificate with classification and notified body, an ISO 13485 certificate with scope and validity, a lot-linked certificate of analysis, and commercial terms including MOQ and Incoterms.
Do dermal fillers contain lidocaine?
Some do. The FDA notes that some dermal fillers contain lidocaine to reduce injection discomfort. Whether a specific SKU contains it should be confirmed on the technical data sheet rather than assumed from the product family.
How should dermal fillers be stored?
AuroThread specifies storage at 2–25°C with a two-year shelf life from the manufacturing date for its HA range, individually packaged. Storage conditions determine whether standard warehousing is adequate and belong in the shipping terms.
B2B disclaimer
This page is published for healthcare professionals, clinics, distributors and OEM buyers. It is not medical advice, a treatment recommendation, a prescribing guide or a substitute for the instructions for use supplied with each product. Product specifications quoted here are taken from AuroThread's own published data at the time of writing and should be re-confirmed on the specification sheet and certificate of analysis for the specific lot before ordering. Regulator and clinical statements are attributed to their sources and summarise public guidance; requirements differ by market and remain the responsibility of the importer or registration holder.
Regulator and clinical sources cited in this guide: the FDA's approved dermal filler materials list, its consumer guidance Dermal Filler Do's and Don'ts, and the ASDS overview of injectable poly-L-lactic acid.
